Jiuzhitang Co., Ltd. (SHE:000989)

China · Delayed Price · Currency is CNY

9.52

+0.28 (3.03%)

Aug 20, 2026, 3:04 PM CST

-20.80% (1Y)

Market Cap	8.06B -22.9%
Revenue (ttm)	2.60B +32.7%
Net Income	329.01M +111.7%
EPS	0.39 +111.8%
Shares Out	846.28M
PE Ratio	24.49
Forward PE	n/a
Dividend	0.30 (3.19%)
Ex-Dividend Date	May 14, 2026

Volume	42,486,873
Open	9.46
Previous Close	9.24
Day's Range	9.24 - 9.67
52-Week Range	7.40 - 12.93
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 3,674

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000989

Full Company Profile

Financial Performance

In 2025, Jiuzhitang's revenue was 2.23 billion, a decrease of -5.99% compared to the previous year's 2.37 billion. Earnings were 222.60 million, an increase of 2.96%.

Financial Statements